Susan Duggan
Geschäftsführer bei TRANSCODE THERAPEUTICS, INC.
Aktive Positionen von Susan Duggan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRANSCODE THERAPEUTICS, INC. | Geschäftsführer | - | - |
Karriereverlauf von Susan Duggan
Ehemalige bekannte Positionen von Susan Duggan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MEDTRONIC PLC | Corporate Officer/Principal | - | - |
Samus Therapeutics, Inc.
 Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | Corporate Officer/Principal | 01.03.2018 | - |
Ausbildung von Susan Duggan
| Colby-Sawyer College | Undergraduate Degree |
| Rivier University | Masters Business Admin |
| Northern Essex Community College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Irland | 2 |
Operativ
| Undergraduate Degree | 2 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MEDTRONIC PLC | Health Technology |
| TRANSCODE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Samus Therapeutics, Inc.
Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | Health Technology |
- Börse
- Insiders
- Susan Duggan
- Erfahrung
